What top creators are saying about Cardiff Oncology Inc.(CRDF)

Clinical-stage biotechnology company.

2 AI-extracted insights from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Not enough scored insights about Cardiff Oncology Inc. in the last 30 days yet.

Top creators covering Cardiff Oncology Inc. (CRDF)

The 1 sources with the most insights about Cardiff Oncology Inc. on Kazuha.

Latest insights about Cardiff Oncology Inc. (CRDF)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Tuesday, July 29, 2025

Very Bearish
Target: $1

The speaker was short, anticipating a clinical trial failure. After the data release, it was described as 'incrementally bad' and not good enough for the stock to go up, as the drug's advantage over the control arm narrowed significantly.

Monday, July 28, 2025

Very Bearish

Speaker is explicitly bearish ahead of a binary data release, stating 'I don't think Cardiff's going to make it' and implying a short position with a 90% chance of failure.

Martin Shkreli
7/28/25 +9%
Martin ShkreliYouTube330 days ago

Discussed alongside Cardiff Oncology Inc. (CRDF)

Other assets that creators frequently mention in the same content as Cardiff Oncology Inc..

Frequently asked

Which podcasters and creators cover Cardiff Oncology Inc. (CRDF) the most?

The most active sources covering Cardiff Oncology Inc. (CRDF) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Cardiff Oncology Inc. (CRDF) are on Kazuha?

Kazuha has indexed 2 AI-extracted insights about Cardiff Oncology Inc. (CRDF) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Cardiff Oncology Inc. (CRDF)?

Creators covering Cardiff Oncology Inc. (CRDF) most frequently also discuss SRPT, ABVX, RGTI, IONQ, QBTS. See the "Discussed alongside" section above for full asset pages.